Patients With Atopic Dermatitis Using Oral Contraceptive Pills or Hormone Replacement Therapy: Long-Term Safety of Upadacitinib for Major Adverse Cardiovascular Events, Venous Thromboembolism, or Malignancy (Excluding Nonmelanoma Skin Cancer). J of Skin [Internet]. 2025 Nov. 10 [cited 2026 Jan. 23];9(6):s613. Available from: https://skin.dermsquared.com/skin/article/view/3815